FDA Lets GSK/Adolor Resume Entereg Work
This article was originally published in The Pink Sheet Daily
Executive Summary
But regulatory hurdles could send GSK on its way, analysts say.
You may also be interested in...
Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use
GSK returns rights to alvimopan in outpatient settings; partnership continues for approved hospital use.
Adolor Seeks New Entereg Partner; Asks FDA To Weigh In On Chronic Use
GSK returns rights to alvimopan in outpatient settings; partnership continues for approved hospital use.
Adolor/GSK’s Entereg Approved By FDA
Cleared at last, hospital constipation drug brings risk management plan.